North Carolina
Chris Lindsell is director of Data Science and Biostatistics for Duke Clinical Research Institute, and professor and co-chief of biostatistics at Duke University. His career has focused on improving clinical research efficiency through better systems, methods, and processes. He leads data coordinating centers for federal and industry supported clinical trials and epidemiological studies ranging in scale from single center to multi-national studies. The target of Dr. Lindsell’s discovery work is in acute and critical care, where he is a recognized expert in biomarker discovery and validation, phenotyping, and designing and executing clinical trials. He has published over 400 papers, holds patents for risk stratification in sepsis and septic shock, and developed a learning health system framework for embedded clinical trials. He currently serves as Editor in Chief for the Journal of Clinical and Translational Science and he is MPI of the Duke CTSA, Vanderbilt’s Trial Innovation Center, and the ARDS, pneumonia and sepsis phenotyping consortium.
ARDS Clinical Research: Data Collection Toward Avancing Phenotypes
Monday, March 23, 2026
1:31 PM - 1:40 PM Central Time
Disclosure(s): Biomeme: Contracted Research (Terminated, June 30, 2024); Cytokinetics: Contracted Research (Ongoing); Nyxoah: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Terminated, June 30, 2025); Persistence Bio: Scientific Advisory Board (Ongoing); Regeneron: Contracted Research (Ongoing); Rocket Pharmaceuticals: Other Financial or Material Support (Ongoing)
